Document is current

Article History

Received: 22 September 2022

Accepted: 8 February 2023

First Online: 28 February 2023

Declarations

:

: Jan Beumer’s institute received research support from AbbVie. Leisha Emens has received research support from Aduro Biotech, AstraZeneca, Breast Cancer Research Foundation, Corvus, Department of Defense, EMD Serono, Genentech, HeritX, Inc., Maxcyte, Merck, National Cancer Institute, NSABP Foundation, Roche, Translational Breast Cancer Research Consortium, and has served as a consultant for AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Celgene, Genentech, Gritstone, Lilly, Macrogenics, Medimmune, Molecuvax, Novartis, Peregrine, Replimune, Roche, Syndax, and Vaccinex. She has also received royalties from Aduro Biotech. Shannon Puhalla has received research support from AbbVie, Pfizer, Lilly, Novartis, Incyte, Covance-Bayer, AstraZeneca, Genentech, Medivation and has been a consultant for AbbVie, MedImmune, Celldex, Puma, Pfizer, AstraZeneca, Esai, and Nanostring. Stacie Shepherd is a former employee of Abbott, AbbVie, and Corcept and holds Abbott, AbbVie, and Corcept stocks.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: The authors would like to thank all of the participating patients and their families and the network of investigators, research nurses and study coordinators. This trial was registered under ClinicalTrials.gov Identifier: NCT01281150.